美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

VanEck Biotech ETF

236.48

-5.5125-2.28%

盤後：236.40-0.0764-0.03%19:30 EDT

成交量：1.16萬

成交額：275.26萬

市值：4.67億

市盈率：- -

高：239.92

開：239.92

低：235.99

收：241.99

52周最高：244.35

52周最低：160.91

股本：197.65萬

流通股本：197.65萬

量比：1.47

換手率：0.59%

股息：0.97

股息率：0.41%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

美國FDA批准胰腺癌突破性藥物獨立藥企Revolution Medicines迎里程碑

环球市场播报

美國食品藥品監督管理局（FDA）批准吉利德治療艾滋病的每日一次複方片劑

美國FDA批准吉利德科學Bixlenvo™上市：每日單片方案為病毒學抑制HIV成人患者提供新選擇，涵蓋複雜治療方案人群

Street View：Revolution的胰腺癌藥物獲批，開啓「變革性」時代

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/BBH"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":236.4764,"timestamp":1787947200000,"preClose":241.9889,"halted":0,"volume":11604,"hourTrading":{"tag":"盘后","latestPrice":236.4,"preClose":236.4764,"latestTime":"19:30 EDT","volume":17,"amount":4021.9212,"timestamp":1787959805637,"change":-0.0764,"changeRate":-0.000323,"amplitude":0},"delay":0,"changeRate":-0.02277997048624953,"floatShares":1976503,"shares":1976503,"eps":0,"marketStatus":"休市中","change":-5.5125,"latestTime":"08-28 16:00:00 EDT","open":239.92,"high":239.92,"low":235.985,"amount":2752569.7547999998,"amplitude":0.016261,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":241.9889,"sharesOutstanding":1976503,"nav":241.97131,"aum":480676735.72,"dividendRate":0.004093,"bidAskSpread":0.001114,"preHourTrading":{"tag":"盘前","latestPrice":242.99,"preClose":241.9889,"latestTime":"08:47 EDT","volume":2,"amount":484.97892,"timestamp":1787921226783,"change":1.0011,"changeRate":0.004137,"amplitude":0.004137},"postHourTrading":{"tag":"盘后","latestPrice":236.4,"preClose":236.4764,"latestTime":"19:30 EDT","volume":17,"amount":4021.9212,"timestamp":1787959805637,"change":-0.0764,"changeRate":-0.000323,"amplitude":0},"volumeRatio":1.473748363860226,"impliedVol":0.1958,"impliedVolPercentile":0.5299},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":1976503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.473748363860226,"shares":1976503,"dividePrice":0.968,"high":239.92,"amplitude":0.016261,"preClose":241.9889,"low":235.985,"week52Low":160.91,"pbRate":"--","week52High":244.345,"institutionHeld":0,"latestPrice":236.4764,"eps":0,"divideRate":0.004093,"volume":11604,"delay":0,"ttmEps":0,"open":239.92,"prevYearClose":189.2649,"prevWeekClose":241.2282,"prevMonthClose":205.5494,"prevQuarterClose":203.2373,"fiveDayClose":241.2282,"twentyDayClose":205.5494,"sixtyDayClose":185.7717},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662061828","title":"美國FDA批准胰腺癌突破性藥物 獨立藥企Revolution Medicines迎里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=2662061828","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662061828?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 18:15","pubTimestamp":1787912149,"startTime":"0","endTime":"0","summary":"Revolution Medicines历时近十年持续攻关，在500人规模临床试验中获得积极数据，最终获得监管批准。为完成交易，戈德史密斯与Warp Drive最大股东赛诺菲协商，将后者持有的Warp Drive多数股权置换为Revolution Medicines的部分股权，最终达成协议。在正式获批前，美国食品药品管理局已通过同情用药项目允许Revolution Medicines提前约四个月向患者分发药物，截至获批时已有超过2000名患者纳入该项目。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-28/doc-inipwhrt5845666.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["RVMD","IE00BJT1NW94.SGD","BK4585","IE00B2B36J28.USD","BK4588","LU0889565916.HKD","BK4139","LABU","IE0009354923.USD","IDNA","PTH","LU0109394709.USD","CANC","BBH","IE0002141913.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036374","title":"美國食品藥品監督管理局（FDA）批准吉利德治療艾滋病的每日一次複方片劑","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036374","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036374?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 05:50","pubTimestamp":1787867453,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）批准吉利德治疗艾滋病的每日一次复方片剂路透8月27日-吉利德科学公司周四表示，美国食品和药物管理局已批准该公司研发的每日一次口服复方药GILD.O，用于治疗HIV病毒载量已降至极低水平的成人患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4S44O24V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","LU0058720904.USD","LU1037948897.HKD","TMED","BK4583","LU2112291526.USD","LU1934455277.USD","BK4585","LU1674673691.USD","LU1037948541.HKD","LU1023059063.AUD","BK4568","IE0002270589.USD","BBH","IE00B3T34201.USD","LU0109394709.USD","SG9999015986.USD","SG9999015952.SGD","LU0965508806.USD","LU0965509101.SGD","SG9999015945.SGD","BIB","SG9999015978.USD","LU2468319806.SGD","LU0114720955.EUR","LU0965509283.SGD","LU0889565916.HKD","IE00B19Z3581.USD","LU1778281490.HKD","BK4139","LU2324357040.USD","IE00BZ1G4Q59.USD","IBB","MEDI","IE00B7SZLL34.SGD","BK4532","LU1934455194.USD","LU1571399168.USD","LU1061106388.HKD","IBBQ","LU1430594728.SGD","BMED","LU0823416689.USD","LU1839511570.USD","LU0289739699.SGD","IE00BKVL7J92.USD","BK4566","TBXU","GILD","LU0861579265.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198194055","title":"美國FDA批准吉利德科學Bixlenvo™上市：每日單片方案為病毒學抑制HIV成人患者提供新選擇，涵蓋複雜治療方案人群","url":"https://stock-news.laohu8.com/highlight/detail?id=1198194055","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198194055?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 05:49","pubTimestamp":1787867358,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局正式批准了吉利德科学旗下新药Bixlenvo。这款每日一次的单片制剂，专为病毒学抑制状态的HIV成人感染者设计——即便是那些正在接受复杂治疗方案的病患，也适用这一新选项。此项获批标志着HIV治疗领域又添一枚重要砝码。Bixlenvo以单片复方形式呈现，将给药频率与用药负担同步压缩，患者无需再面对繁琐的多药组合。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","IE00B19Z3B42.SGD","LU0109394709.USD","LU1934455277.USD","LU2089984988.USD","GILD","LU0882574055.USD","LU0859254822.USD","BK4550","LU0058720904.USD","LU0122379950.USD","LU0234570918.USD","LU1023059063.AUD","BK4583","LU1037948897.HKD","LU1066053197.SGD","BK4139","LU1674673691.USD","SG9999015952.SGD","LU0965509010.AUD","BK4566","LU0114720955.EUR","LU0823416689.USD","IE00B7SZLL34.SGD","LU1066051498.USD","LU2087621335.USD","LU1571399168.USD","LU2468319806.SGD","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD","LU0861579265.USD","MEDI","LU1778281490.HKD","TBXU","LU1061106388.HKD","LU0889565916.HKD","LU0965508806.USD","LU0965509283.SGD","LU1934455194.USD","LU1839511570.USD","LU1934455863.HKD","LU0289739699.SGD","BK4532","IBBQ","IBB","LU0320765992.SGD","LU0965509101.SGD","LU1674673428.USD","BK4568","SG9999015978.USD","LU1430594728.SGD","SG9999015945.SGD","IE0002270589.USD","LU1057294990.SGD","LU2112291526.USD","LU2357627491.SGD","IE00BKVL7J92.USD","SG9999015986.USD","TMED","IE00B3T34201.USD","IE00B19Z3581.USD","BK4585","LU1037948541.HKD","BBH","LU1585245621.USD","BK4588","BK4578","BMED","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662704894","title":"Street View：Revolution的胰腺癌藥物獲批，開啓「變革性」時代","url":"https://stock-news.laohu8.com/highlight/detail?id=2662704894","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662704894?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 19:36","pubTimestamp":1787830591,"startTime":"0","endTime":"0","summary":"BUZZ-Street View：Revolution的胰腺癌药物获批，开启“变革性”时代8月27日-** Revolution Medicines旗下RVMD.O公司研发的、具有突破性的  胰腺癌药物Rasonque于周三获得美国FDA批准** RVMD股价盘前上涨3%，报222美元；该股平均评级为“买入”，目标价中位数为240美元——路孚特数据** 监管部门批准后，至少有7位分析师上调了目标价化疗后时代来临？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4T44O15A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","PTH","BK4139","IE0002141913.USD","IE0009355771.USD","LU0320765992.SGD","BBH","IDNA","IE0009354923.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU0889565916.HKD","IE00BJJMRZ35.SGD","RVMD","IE00B4R5TH58.HKD","LU0109394709.USD","CANC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":37,"pageCount":1,"totalSize":146,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BBH\",params:#limit:6,delay:false,,,undefined,":[]}}